Oricef 250 mg/vial (IV Injection)
250 mg vial: ৳ 130.00
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Healthcare pharmaceuticals ltd |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
- Broad-spectrum parenteral cephalosporin antibiotic
- Potent bactericidal activity
- Interference with bacterial cell wall synthesis
- Long plasma elimination half-life
- High stability in the presence of beta lactamases
- Non-metabolized
Dosage
- Usual dose for adults: 1 to 2 gm by intravenous or intramuscular administration once a day
- Maximum adult dose: 4 gm/day
- Usual dose for infants and children: 50 to 75 mg/kg intravenous or intramuscular administration once a day
- Maximum pediatric dose: 2 gm/day
- Duration of therapy: 4 to 14 days, longer for complicated infections
Administration
- Preparation of solutions for intramuscular/intravenous injections
- Intramuscular injection preparation in Lidocaine HCI 1% injection
- Intravenous injection preparation in Water for injection
- Administration over 2-4 minutes for intramuscular or intravenous injection
- Tubing infusion over a period of 30 minutes
- Patient tolerance test recommended before starting treatment
Interaction
- No drug interactions reported
Contraindications
- Hypersensitivity to cephalosporin antibiotics
Side Effects
- Gastro-intestinal effects including diarrhea, nausea, vomiting, stomatitis, and glossitis
- Cutaneous reactions including rash, pruritus, urticaria, edema, and erythema multiforme
- Hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia, and neutropenia
- Hepatic reactions including elevations of SGOT or SGPT, bilirubinemia
- CNS reactions including nervousness, confusion, sleep disturbances, headache, hyperactivity, convulsion, hypertonia, and dizziness
- Rare occurrence of local phlebitis following intravenous administration
Pregnancy & Lactation
- Safety in human pregnancy not established
- Caution in lactating mothers
Precautions & Warnings
- Risk of anaphylactic shock
- Possibility of gallbladder conditions
- Monitoring blood picture during prolonged treatment
Use in Special Populations
- Avoid in premature and newborn neonates (up to 28 days of age)
Overdose Effects
- No specific antidote, treatment should be symptomatic
Therapeutic Class
- Third generation Cephalosporins
Storage Conditions
- Store below 30°C, away from light and moisture